Avanos Medical AVNS Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Avanos Medical’s reported figures.
Based on trailing twelve months.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's return on equity?
- Avanos Medical (AVNS) reported return on equity of -9.2% in Q1 2026.
- How has Avanos Medical's return on equity changed year-over-year?
- Avanos Medical's return on equity increased by 75.3% year-over-year, from -37.2% to -9.2%.
- What is the long-term trend for Avanos Medical's return on equity?
- Over 4 years (2020 to 2025), Avanos Medical's return on equity has grown at a 41.1% compound annual growth rate (CAGR), from -2.3% to -9.1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.